Reductions in cardiovascular risk associated with dapagliflozin treatment in patients with type 2 diabetes are most pronounced in those who have both reduced kidney function and albuminuria, a recent analysis shows.
Findings from a recent study emphasize the importance of neurocognitive assessment in men undergoing ADT, especially in younger patients, according to investigators.
Patients’ risk of pathologic upgrading may depend on their intermediate-risk factor (Gleason score 3+4, PSA level of 10-20 ng/mL, and cT2b-c disease).
Investigators report encouraging results from a small observational study testing the effect of preemptive therapeutic plasma exchange and rituximab in kidney transplant recipients whose primary cause of kidney failure was focal segmental glomerulosclerosis.
In a study of Black patients with COVID-19, those with 2 APOL1 risk alleles have increased odds of acute kidney injury.
Oral sodium bicarbonate therapy given to patients with chronic kidney disease increases urinary pH but also increases urinary citrate levels, which may mitigate the risk for calcium phosphate stone formation.
Autosomal dominant polycystic kidney disease progresses to kidney failure faster in Hispanic patients than in those of other races or ethnicities, a study found.
Each 1 mEq/L increase in serum bicarbonate in kidney transplant recipients is associated with a 10% reduction in graft failure risk, a study found.
Nearly 74% of hemodialysis patients experienced pre-dialysis hyperkalemia within 1 year of enrollment in the Dialysis Outcomes and Practice Patterns Study, according to investigators.
New study is the first to characterize pegloticase use in the dialysis population.
